BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27644917)

  • 1. [Left temporal arachnoid cyst and specific learning disorders associated with Pervasive Developmental Disorders - Not Otherwise Specified (PDD-NOS): contributions of an integrative neuropsychomotor, neuropsychological, psychopathological and neurosurgical approach about a case report in a child (François)].
    Vaivre-Douret L; Boschi A; Cuny ML; Clouard C; Mosser A; Golse B; Philippe A; Bourgeois M; Boddaert N; Puget S
    Encephale; 2016 Dec; 42(6):582-588. PubMed ID: 27644917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic rules for children with PDD-NOS and multiple complex developmental disorder.
    Buitelaar JK; van der Gaag RJ
    J Child Psychol Psychiatry; 1998 Sep; 39(6):911-9. PubMed ID: 9758199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism and other pervasive developmental disorders: exploring the dimensional view.
    Myhr G
    Can J Psychiatry; 1998 Aug; 43(6):589-95. PubMed ID: 9729686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the borders of autism spectrum disorder: lessons from the former diagnosis of pervasive developmental disorder not otherwise specified.
    Coutelle R; Coulon N; Schröder CM; Putois O
    Front Psychiatry; 2023; 14():1149580. PubMed ID: 38173703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal lobe arachnoid cyst-attention deficit disorder syndrome: role of the electroencephalogram in diagnosis.
    Millichap JG
    Neurology; 1997 May; 48(5):1435-9. PubMed ID: 9153486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pervasive developmental disorders not otherwise specified. A developmental-psychopathological approach for the development of made-to-measure treatment planning.
    Verheij F; van Loon H
    Acta Paedopsychiatr; 1992; 55(4):235-42. PubMed ID: 1492555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theory of mind and emotion-recognition functioning in autistic spectrum disorders and in psychiatric control and normal children.
    Buitelaar JK; van der Wees M; Swaab-Barneveld H; van der Gaag RJ
    Dev Psychopathol; 1999; 11(1):39-58. PubMed ID: 10208355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders.
    Hofvander B; Delorme R; Chaste P; Nydén A; Wentz E; Ståhlberg O; Herbrecht E; Stopin A; Anckarsäter H; Gillberg C; Råstam M; Leboyer M
    BMC Psychiatry; 2009 Jun; 9():35. PubMed ID: 19515234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between attention-deficit/hyperactivity disorder and pervasive developmental disorder--not otherwise specified.
    Jensen VK; Larrieu JA; Mack KK
    Clin Pediatr (Phila); 1997 Oct; 36(10):555-61. PubMed ID: 9336673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral arachnoid cysts, seizures and severe encephalopathy: case report.
    Pascual-Castroviejo I; Pascual-Pascual SI
    Neuropediatrics; 1994 Feb; 25(1):42-3. PubMed ID: 8208351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition in children with arachnoid cysts - A five-year follow-up after microneurosurgical fenestration.
    Adolfsson T; Edström E; Tedroff K; Sandvik U
    Acta Neurochir (Wien); 2024 May; 166(1):226. PubMed ID: 38777952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of genetic evaluation in children with pervasive developmental disorder.
    Chudley AE; Gutierrez E; Jocelyn LJ; Chodirker BN
    J Dev Behav Pediatr; 1998 Oct; 19(5):321-5. PubMed ID: 9809261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pervasive developmental disorder, not otherwise specified: primary care perspectives.
    Cascio RS; Kilmon CA
    Nurse Pract; 1997 Jul; 22(7):11, 15-6, 18 passim. PubMed ID: 9253013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.
    Russo AJ; Devito R
    Biomark Insights; 2011; 6():127-33. PubMed ID: 22174567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed language onset as a predictor of clinical symptoms in pervasive developmental disorders.
    Eisenmajer R; Prior M; Leekam S; Wing L; Ong B; Gould J; Welham M
    J Autism Dev Disord; 1998 Dec; 28(6):527-33. PubMed ID: 9932239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating attention-deficit/hyperactivity disorder from pervasive developmental disorder not otherwise specified.
    Roeyers H; Keymeulen H; Buysse A
    J Learn Disabil; 1998; 31(6):565-71. PubMed ID: 9813954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alexithymia, depression and anxiety in parents of children with neurodevelopmental disorder: Comparative study of autistic disorder, pervasive developmental disorder not otherwise specified and attention deficit-hyperactivity disorder.
    Durukan İ; Kara K; Almbaideen M; Karaman D; Gül H
    Pediatr Int; 2018 Mar; 60(3):247-253. PubMed ID: 29290095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verbal memory and Performance IQ predict theory of mind and emotion recognition ability in children with autistic spectrum disorders and in psychiatric control children.
    Buitelaar JK; van der Wees M; Swaab-Barneveld H; van der Gaag RJ
    J Child Psychol Psychiatry; 1999 Sep; 40(6):869-81. PubMed ID: 10509882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating pervasive developmental disorder not otherwise specified from autism and language disorders.
    Mayes L; Volkmar F; Hooks M; Cicchetti D
    J Autism Dev Disord; 1993 Mar; 23(1):79-90. PubMed ID: 7681820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood Onset Pervasive Developmental Disorder.
    Burd L; Fisher W; Kerbeshian J
    J Child Psychol Psychiatry; 1988 Mar; 29(2):155-63. PubMed ID: 3372612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.